Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 23

1.

Conditionally Stabilized dCas9 Activator for Controlling Gene Expression in Human Cell Reprogramming and Differentiation.

Balboa D, Weltner J, Eurola S, Trokovic R, Wartiovaara K, Otonkoski T.

Stem Cell Reports. 2015 Sep 8;5(3):448-59. doi: 10.1016/j.stemcr.2015.08.001.

2.

Somatic progenitor cell vulnerability to mitochondrial DNA mutagenesis underlies progeroid phenotypes in Polg mutator mice.

Ahlqvist KJ, Hämäläinen RH, Yatsuga S, Uutela M, Terzioglu M, Götz A, Forsström S, Salven P, Angers-Loustau A, Kopra OH, Tyynismaa H, Larsson NG, Wartiovaara K, Prolla T, Trifunovic A, Suomalainen A.

Cell Metab. 2012 Jan 4;15(1):100-9. doi: 10.1016/j.cmet.2011.11.012.

3.

CIP2A increases self-renewal and is linked to Myc in neural progenitor cells.

Kerosuo L, Fox H, Perälä N, Ahlqvist K, Suomalainen A, Westermarck J, Sariola H, Wartiovaara K.

Differentiation. 2010 Jul;80(1):68-77. doi: 10.1016/j.diff.2010.04.003. Epub 2010 May 5.

PMID:
20447748
4.

Timing of the cell cycle exit of differentiating hippocampal neural stem cells.

Järvinen E, Angers-Loustau A, Osiceanu AM, Wartiovaara K.

Int J Stem Cells. 2010 May;3(1):46-53.

5.

Amplification and overexpression of KIT, PDGFRA, and VEGFR2 in medulloblastomas and primitive neuroectodermal tumors.

Blom T, Roselli A, Häyry V, Tynninen O, Wartiovaara K, Korja M, Nordfors K, Haapasalo H, Nupponen NN.

J Neurooncol. 2010 Apr;97(2):217-24. doi: 10.1007/s11060-009-0014-2. Epub 2009 Sep 25.

PMID:
19779861
6.

Unraveling the disease pathogenesis behind lethal hydrolethalus syndrome revealed multiple changes in molecular and cellular level.

Honkala H, Lahtela J, Fox H, Gentile M, Pakkasjärvi N, Salonen R, Wartiovaara K, Jauhiainen M, Kestilä M.

Pathogenetics. 2009 Apr 28;2(1):2. doi: 10.1186/1755-8417-2-2.

7.

Myc increases self-renewal in neural progenitor cells through Miz-1.

Kerosuo L, Piltti K, Fox H, Angers-Loustau A, Häyry V, Eilers M, Sariola H, Wartiovaara K.

J Cell Sci. 2008 Dec 1;121(Pt 23):3941-50. doi: 10.1242/jcs.024802. Epub 2008 Nov 11.

8.

KIT overexpression induces proliferation in astrocytes in an imatinib-responsive manner and associates with proliferation index in gliomas.

Blom T, Fox H, Angers-Loustau A, Peltonen K, Kerosuo L, Wartiovaara K, Linja M, Jänne OA, Kovanen P, Haapasalo H, Nupponen NN.

Int J Cancer. 2008 Aug 15;123(4):793-800. doi: 10.1002/ijc.23576.

9.

Copy number alterations of the polycomb gene BMI1 in gliomas.

Häyry V, Tanner M, Blom T, Tynninen O, Roselli A, Ollikainen M, Sariola H, Wartiovaara K, Nupponen NN.

Acta Neuropathol. 2008 Jul;116(1):97-102. doi: 10.1007/s00401-008-0376-0. Epub 2008 Apr 22.

PMID:
18427816
10.

Stem cell protein BMI-1 is an independent marker for poor prognosis in oligodendroglial tumours.

Häyry V, Tynninen O, Haapasalo HK, Wölfer J, Paulus W, Hasselblatt M, Sariola H, Paetau A, Sarna S, Niemelä M, Wartiovaara K, Nupponen NN.

Neuropathol Appl Neurobiol. 2008 Oct;34(5):555-63. doi: 10.1111/j.1365-2990.2008.00949.x. Epub 2008 Mar 10.

PMID:
18346113
11.

PlasmaDNA: a free, cross-platform plasmid manipulation program for molecular biology laboratories.

Angers-Loustau A, Rainy J, Wartiovaara K.

BMC Mol Biol. 2007 Sep 17;8:77.

12.

Neural precursor cells from a fatal human motoneuron disease differentiate despite aberrant gene expression.

Pakkasjärvi N, Kerosuo L, Nousiainen H, Gentile M, Saharinen J, Suhonen S, Sariola H, Peltonen L, Kestilä M, Wartiovaara K.

Dev Neurobiol. 2007 Feb 15;67(3):270-84.

13.

E6/E7 oncogenes increase and tumor suppressors decrease the proportion of self-renewing neural progenitor cells.

Piltti K, Kerosuo L, Hakanen J, Eriksson M, Angers-Loustau A, Leppä S, Salminen M, Sariola H, Wartiovaara K.

Oncogene. 2006 Aug 10;25(35):4880-9. Epub 2006 Mar 13.

PMID:
16532024
14.

Crosstalk between Jagged1 and GDNF/Ret/GFRalpha1 signalling regulates ureteric budding and branching.

Kuure S, Sainio K, Vuolteenaho R, Ilves M, Wartiovaara K, Immonen T, Kvist J, Vainio S, Sariola H.

Mech Dev. 2005 Jun;122(6):765-80.

15.

Characterization of the NF2 protein merlin and the ERM protein ezrin in human, rat, and mouse central nervous system.

Grönholm M, Teesalu T, Tyynelä J, Piltti K, Böhling T, Wartiovaara K, Vaheri A, Carpén O.

Mol Cell Neurosci. 2005 Apr;28(4):683-93.

PMID:
15797715
16.

N-myc promotes survival and induces S-phase entry of postmitotic sympathetic neurons.

Wartiovaara K, Barnabe-Heider F, Miller FD, Kaplan DR.

J Neurosci. 2002 Feb 1;22(3):815-24.

17.

Distribution of glial cell line-derived neurotrophic factor mRNA in human colon suggests roles for muscularis mucosae in innervation.

Wartiovaara K, Salo M, Sainio K, Rintala R, Sariola H.

J Pediatr Surg. 1998 Oct;33(10):1501-6.

PMID:
9802801
18.

Mutation analysis of the glial cell line-derived neurotrophic factor gene in Parkinson's disease.

Wartiovaara K, Hytönen M, Vuori M, Paulin L, Rinne J, Sariola H.

Exp Neurol. 1998 Aug;152(2):307-9.

PMID:
9710530
19.

Hirschsprung's disease genes and the development of the enteric nervous system.

Wartiovaara K, Salo M, Sariola H.

Ann Med. 1998 Feb;30(1):66-74. Review.

PMID:
9556091
20.

Glial-cell-line-derived neurotrophic factor is required for bud initiation from ureteric epithelium.

Sainio K, Suvanto P, Davies J, Wartiovaara J, Wartiovaara K, Saarma M, Arumäe U, Meng X, Lindahl M, Pachnis V, Sariola H.

Development. 1997 Oct;124(20):4077-87.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk